Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BFRIW

Biofrontera (BFRIW)

Biofrontera Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BFRIW
DateTimeSourceHeadlineSymbolCompany
06/24/20248:30AMGlobeNewswire Inc.Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampNASDAQ:BFRIWBiofrontera Inc
06/14/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
05/22/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BFRIWBiofrontera Inc
05/22/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
05/15/20245:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BFRIWBiofrontera Inc
05/10/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BFRIWBiofrontera Inc
12/16/20228:30AMGlobeNewswire Inc.Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersNASDAQ:BFRIWBiofrontera Inc
11/30/20222:08PMGlobeNewswire Inc.Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
11/28/202211:05AMGlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022NASDAQ:BFRIWBiofrontera Inc
11/21/20228:48AMGlobeNewswire Inc.Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkNASDAQ:BFRIWBiofrontera Inc
11/14/20228:45AMGlobeNewswire Inc.Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
11/10/202211:52AMGlobeNewswire Inc.Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022NASDAQ:BFRIWBiofrontera Inc
11/08/20224:45PMGlobeNewswire Inc.Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
10/31/20228:55AMGlobeNewswire Inc.Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGNASDAQ:BFRIWBiofrontera Inc
10/24/20227:45AMGlobeNewswire Inc.Biofrontera Inc. Names Fred Leffler as Chief Financial OfficerNASDAQ:BFRIWBiofrontera Inc
10/20/202211:40AMGlobeNewswire Inc.Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceNASDAQ:BFRIWBiofrontera Inc
10/18/202210:30AMGlobeNewswire Inc.Biofrontera Inc. to Sponsor the 2022 Fall Clinical Dermatology ConferenceNASDAQ:BFRIWBiofrontera Inc
10/14/20228:40AMGlobeNewswire Inc.Biofrontera Inc. Adopts Limited Duration Shareholder Rights PlanNASDAQ:BFRIWBiofrontera Inc
10/12/20222:00PMGlobeNewswire Inc.BIOFRONTERA INC. TO PARTICIPATE IN RENMARK’S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022NASDAQ:BFRIWBiofrontera Inc
10/05/20225:00PMGlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
09/29/202210:04AMGlobeNewswire Inc.Biofrontera Inc. to Present at the Roth Inaugural Healthcare Opportunities ConferenceNASDAQ:BFRIWBiofrontera Inc
09/26/20228:30AMGlobeNewswire Inc.Biofrontera Inc.’s Marketing Campaign and Website for Ameluz Won 2022 PM360 Trailblazer AwardsNASDAQ:BFRIWBiofrontera Inc
09/13/20228:30AMGlobeNewswire Inc.Biofrontera Inc. Names Gerard DiGirolamo as National Sales DirectorNASDAQ:BFRIWBiofrontera Inc
09/06/202210:31AMGlobeNewswire Inc.Biofrontera Inc. Announces Notice of Allowance for Nanoemulsion Composition-of-Matter U.S. PatentNASDAQ:BFRIWBiofrontera Inc
08/18/202211:04AMGlobeNewswire Inc.Biofrontera Inc.’s Leslie Hopkins Named PM360 Trailblazer 2022 Brand Champion for DermatologyNASDAQ:BFRIWBiofrontera Inc
08/12/20228:33AMGlobeNewswire Inc.Biofrontera Inc. Reports Second Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:BFRIWBiofrontera Inc
08/04/20228:30AMGlobeNewswire Inc.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022NASDAQ:BFRIWBiofrontera Inc
08/01/202211:00AMGlobeNewswire Inc.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbHNASDAQ:BFRIWBiofrontera Inc
07/27/20228:45AMGlobeNewswire Inc.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private PlacementNASDAQ:BFRIWBiofrontera Inc
07/12/20228:00AMGlobeNewswire Inc.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022NASDAQ:BFRIWBiofrontera Inc
 Showing the most relevant articles for your search:NASDAQ:BFRIW